Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-01

Clinical Trial Update: Terbinafine Hydrochloride for the Treatment of Otomycosis [NA]

View source ↗

Summary

A clinical trial sponsored by Assiut University is evaluating Terbinafine Hydrochloride for otomycosis and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Terbinafine hydrochloride (Terbinafine hydrochloride)

Snippet

Sponsor: Assiut University | Conditions: Otomycosis, Fungal Ear Infection | NA | Status: NOT_YET_RECRUITING